Paper Details

Paper Title

Second-line rituximab-bendamustine versus rituximab-gemcitabine-oxaliplatin in diffuse large B-cell lymphoma in the real world.

Paper Journal Title

J Comp Eff Res

Paper Citation Count

Paper Publication Year

2019

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Raluca Ionescu-Ittu

Column Actions